{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:57:45Z","timestamp":1757609865639,"version":"3.44.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to construct and validate a fusion diagnostic model based on Fluorodeoxyglucose-Positron Emission Tomography\/Computed Tomography(FDG-PET\/CT) radiomics for predicting overall survival of multiple myeloma (MM) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 199 patients newly diagnosed with MM were included from two centers. All patients underwent whole-body PET<jats:bold>\/<\/jats:bold>CT scans within one month before the initiation of treatment and were followed up for over five years. Radiomic features of MM were extracted from CT images and dimensionality reduction was performed by LASSO regression analysis. Cox Proportional Hazards Model was then constructed to predict patient survival. A clinical-radiomic fusion model was constructed by integrating independent clinical risk factors, including comprehensive laboratory parameters, R-ISS, and PET functional metabolic parameters, with the radiomic model. The discrimination ability of the model was evaluated using the C-index, and it\u2019s calibration was assessed using calibration curves.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The C-indexes for the radiomics model in the training and testing cohorts were 0.736 and 0.708, respectively; for the clinical model, they were 0.676 and 0.696, respectively; and for the integrated model, they were 0.791 and 0.776, respectively. The integrated diagnostic model outperformed both the radiomics and clinical models, showcasing higher discriminative ability and improved calibration. In the training set, the C-index was 0.791 (95% confidence interval [CI]: 0.713-0.853), with an ICI of 0.015, E50 of 0.014, and AIC of 10.987. In the testing set, the C-index was 0.776 (95% CI: 0.654\u20130.894), with an ICI of 0.069, E50 of 0.04, and AIC of 11.492.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This integrated prediction model exhibited satisfactory performance in predicting survival outcomes for patients diagnosed with MM and improved precision in discriminating between patients with a good prognosis and poor prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1486495","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:37:51Z","timestamp":1756899471000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of FDG-PET\/CT based radiomics analysis in newly-diagnosed multiple myeloma: a comparative study with clinical assessment"],"prefix":"10.3389","volume":"15","author":[{"given":"Fei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baiyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangwen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaochun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_159009","article-title":"Updated diagnostic criteria and staging system for multiple myeloma","volume":"36","author":"Rajkumar","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"(7)","DOI":"10.3390\/cancers12071759","article-title":"Natural history and prognostic factors at first relapse in multiple myeloma","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/cells11152308","article-title":"Bone disease in multiple myeloma: biologic and clinical implications","volume":"11","author":"Zachary","year":"2022","journal-title":"Cells."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group","volume":"22","author":"Terpos","year":"2021","journal-title":"Lancet Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.1038\/s41467-022-35358-3","article-title":"Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease","volume":"13","author":"Leng","year":"2022","journal-title":"Nat Commun."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1692","article-title":"Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease","volume":"20","author":"Pianko","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/02841851211003287","article-title":"Radiation exposure and establishment of diagnostic reference levels of whole-body low-dose CT for the assessment of multiple myeloma with second- and third-generation dual-source CT","volume":"63","author":"Sebastian","year":"2021"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3348\/jksr.2021.0179","article-title":"Imaging for Multiple Myeloma according to the Recent International Myeloma Working Group Guidelines: Analysis of Image Acquisition Techniques and Response Evaluation in Whole-Body MRI according to MY-RADS","volume":"84","author":"Son","year":"2023"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7005","article-title":"MRI of spinal bone marrow: part I, techniques and normal age-related appearances","volume":"197","author":"Shah","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2022.10.008","article-title":"Clinical value of FDG-PET\/CT in multiple myeloma: an update","volume":"53","author":"Bezzi","year":"2023","journal-title":"Semin Nucl Med."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06088-x","article-title":"A prognostication system based on clinical parameters and [F]-FDG PET\/CT in patients with newly diagnosed multiple myeloma","volume":"50","author":"Li","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2329029","DOI":"10.1080\/16078454.2024.2329029","article-title":"Construction and validation of an (18)F-FDG-PET\/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients","volume":"29","author":"Xiaoqing","year":"2024","journal-title":"Hematology."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-213280","article-title":"F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma","volume":"114","author":"Bartel","year":"2009","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"(24)","DOI":"10.3390\/jcm12247669","article-title":"Positron emission tomography-derived radiomics and artificial intelligence in multiple myeloma: state-of-the-art","volume":"12","author":"Manco","year":"2023","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/diagnostics13122021","article-title":"Radiomics analysis for multiple myeloma: A systematic review with radiomics quality scoring","volume":"13","author":"Klontzas","year":"2023","journal-title":"Diagnostics (Basel)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/medicina57020094","article-title":"Quantitative imaging and radiomics in multiple myeloma: A potential opportunity","volume":"57","author":"Tagliafico","year":"2021","journal-title":"Medicina (Kaunas)."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood-2012-08-451690","article-title":"Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy","volume":"3","author":"Saad","year":"2013","journal-title":"Blood."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of (18)F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group","volume":"18","author":"Cavo","year":"2017","journal-title":"Lancet Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","article-title":"Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing","volume":"8","author":"Rasche","year":"2017","journal-title":"Nat Commun."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06668-z","article-title":"Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [(18)F]FDG PET\/CT predicts survival in multiple myeloma","volume":"51","author":"Christos","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10916-024-02040-8","article-title":"3D CNN-based deep learning model-based explanatory prognostication in patients with multiple myeloma using whole-body MRI","volume":"48","author":"Kento","year":"2024","journal-title":"J Med Syst."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14401","article-title":"Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response","volume":"176","author":"Latifoltojar","year":"2017","journal-title":"Br J Haematol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.981769","article-title":"Differentiation between spinal multiple myeloma and metastases originated from lung using multi-view attention-guided network","volume":"12","author":"Kaili","year":"2022","journal-title":"Front Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"100599","DOI":"10.1016\/j.jbo.2024.100599","article-title":"Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study","volume":"45","author":"Jiashi","year":"2024","journal-title":"J Bone Oncol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709813","article-title":"MRI-based bone marrow radiomics nomogram for prediction of overall survival in patients with multiple myeloma","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12880-021-00605-4","article-title":"Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Med Imaging"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-023-01710-w","article-title":"Radiomics and machine learning analysis by computed tomography and magnetic resonance imaging in colorectal liver metastases prognostic assessment","volume":"128","author":"Granata","year":"2023","journal-title":"Radiol Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.89","article-title":"International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma","volume":"23","author":"Dimopoulos","year":"2009","journal-title":"Leukemia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41408-021-00577-2","article-title":"Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and F-FDG PET\/CT","volume":"11","author":"Cho","year":"2021","journal-title":"Blood Cancer J."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1486495\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:37:52Z","timestamp":1756899472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1486495\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":31,"alternative-id":["10.3389\/fonc.2025.1486495"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1486495","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"1486495"}}